BlackRock’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-288,369
Closed -$1.17M 5410
2025
Q1
$1.17M Buy
288,369
+3,117
+1% +$12.6K ﹤0.01% 4108
2024
Q4
$913K Buy
285,252
+75,669
+36% +$242K ﹤0.01% 4193
2024
Q3
$469K Buy
209,583
+6,723
+3% +$15.1K ﹤0.01% 4296
2024
Q2
$436K Buy
202,860
+37,416
+23% +$80.4K ﹤0.01% 4326
2024
Q1
$339K Sell
165,444
-1,072
-0.6% -$2.2K ﹤0.01% 4415
2023
Q4
$381K Buy
166,516
+62,828
+61% +$144K ﹤0.01% 4416
2023
Q3
$176K Sell
103,688
-13,467
-11% -$22.9K ﹤0.01% 4651
2023
Q2
$289K Buy
117,155
+18,231
+18% +$45K ﹤0.01% 4548
2023
Q1
$223K Buy
98,924
+3,055
+3% +$6.87K ﹤0.01% 4658
2022
Q4
$490K Buy
95,869
+233
+0.2% +$1.19K ﹤0.01% 4526
2022
Q3
$995K Sell
95,636
-683
-0.7% -$7.11K ﹤0.01% 4393
2022
Q2
$992K Buy
96,319
+3,587
+4% +$36.9K ﹤0.01% 4446
2022
Q1
$1.64M Buy
92,732
+174
+0.2% +$3.08K ﹤0.01% 4380
2021
Q4
$2.88M Sell
92,558
-960
-1% -$29.9K ﹤0.01% 4183
2021
Q3
$3.09M Buy
93,518
+11,232
+14% +$371K ﹤0.01% 4085
2021
Q2
$2.43M Sell
82,286
-272,120
-77% -$8.03M ﹤0.01% 4109
2021
Q1
$11.1M Buy
354,406
+30,346
+9% +$953K ﹤0.01% 3445
2020
Q4
$8.59M Buy
324,060
+17,094
+6% +$453K ﹤0.01% 3378
2020
Q3
$8.23M Buy
306,966
+73,888
+32% +$1.98M ﹤0.01% 3246
2020
Q2
$4.61M Buy
233,078
+60,533
+35% +$1.2M ﹤0.01% 3482
2020
Q1
$2.61M Buy
172,545
+21,135
+14% +$319K ﹤0.01% 3511
2019
Q4
$2.61M Sell
151,410
-100,028
-40% -$1.72M ﹤0.01% 3651
2019
Q3
$6.26M Sell
251,438
-29,519
-11% -$735K ﹤0.01% 3379
2019
Q2
$8.51M Buy
280,957
+117,407
+72% +$3.56M ﹤0.01% 3285
2019
Q1
$4.68M Buy
163,550
+54
+0% +$1.55K ﹤0.01% 3400
2018
Q4
$2.98M Sell
163,496
-39
-0% -$710 ﹤0.01% 3525
2018
Q3
$5.85M Buy
163,535
+158,032
+2,872% +$5.65M ﹤0.01% 3421
2018
Q2
$164K Buy
+5,503
New +$164K ﹤0.01% 4306